Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

The American Academy of Pediatrics had earlier urged parents to get young children vaccinated against Covid — pushing back ...

While Moderna is certainly enthusiastic about its near-term mRNA prospects, the company’s COVID-19 business is going through an odd patch, which has afflicted pandemic players of all stripes.

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement -- should consider investing in: Intuitive Surgical ( ISRG 0.67%) and ...

Moderna has lodged two new lawsuits at the High Court in Dublin, Ireland, and the Brussels Commercial Court in Belgium, Juve Patent first reported. This adds to a complex web of ongoing mRNA ...

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...

Moderna plans to submit the latest data from the teens to the U.S. Food and Drug Administration to expand the current authorization for its vaccine to children as young as 12 years old.

Moderna CEO and billionaire Stéphane Bancel recently told The Wall Street Journal that Moderna may quadruple the price of their Covid-19 mRNA vaccines. (Photo by JOEL SAGET/AFP via Getty Images) ...